EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up

Sabine Zitzmann-Kolbe iD, Yvonne Remde, Ingrid Moen iD, Balázs Madas iD, László Mázik, Frans Suurs, Steffen Happel iD, Martin Schäfer, Christoph Schatz iD, Harun Taş iD, Urs B Hagemann iD, Martina Benešová-Schäfer iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025-12 · 53 (1) · 633-646

DOI: 10.1007/s00259-025-07427-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 01.07.2025. Verfasst von Sabine Zitzmann-Kolbe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bayer AG, Berlin, Germany. Hauptthemen laut MEDLINE: Bismuth, Radioisotopes, Actinium. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Krebsforschungszentrum (DKFZ).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Despite the clinical evidence of actinium-225 ( 225 Ac)-based targeted alpha therapies (TαT) efficacy, optimized treatment regimens are needed to improve overall clinical response rates and decrease toxicities. The nuclear recoil effect of 225 Ac and its resulting daughter nuclides have been hypothesized to contribute to non-targeted damage. However, a lack of generator concepts for radionuclidically pure francium-221 ( 221 Fr), involvement of strong acids for elution, and its short half-life (4.8 min), has limited in vivo studies. Here, we report on a successful application of an 225 Ac/ 221 Fr generator concept and the in vivo distribution of 221 Fr and bismuth-213 ( 213 Bi).

Methods

The immobilization of 225 Ac and elution of 221 Fr was performed on a LN2 resin column. The biodistribution of 221 Fr and 213 Bi was investigated in male SCID mice with LNCaP tumors at 5 and 15 min p.i.

Results

Our results indicate that LN2 resin is a highly efficient resin for selective separation of 225 Ac and 221 Fr. The use of 0.1 M NaOAc enabled continuous elution at a constant pH. The biodistribution study revealed a fast distribution of 221 Fr and 213 Bi already 5 min p.i. We observed a strong accumulation of 221 Fr to the kidneys, salivary glands and small intestine. In 213 Bi-injected mice, the highest accumulation was in kidney and liver.

Conclusion

We present an unprecedented concept utilizing LN2 resin in 225 Ac/ 221 Fr generator applications. Successfully eluted and injected 221 Fr fractions showed strong accumulation of 221 Fr and 213 Bi in key organs. Our data provide preliminary evidence of the potential contribution of recoiled progeny radionuclides to side-effects in non-targeted organs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BismuthRadioisotopesActiniumAnimalsMiceTissue DistributionMaleMice, SCIDHumansCell Line, TumorRadiochemistry

Stichwörter der Autor:innen

Actinium-225Bismuth-213Francium-221Radionuclide generatorsRadionuclide-specific organ accumulationTargeted alpha therapies

Substanzen

BismuthRadioisotopesActiniumActinium-225Bismuth-213

Autor:innen und Institutionen

  • Bayer AG, Berlin, Germany.
  • Life Molecular Imaging, Berlin, Germany.
  • Service Unit for Radiopharmaceuticals and Preclinical Studies, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany.
  • Bayer AS, Oslo, Norway.
  • Environmental Physics Department, Institute for Energy Security and Environmental Safety, HUN-REN Centre for Energy Research, Konkoly-Thege Miklós út 29-33, Budapest, 1121, Hungary.
  • Doctoral School of Physics, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/A, Budapest, 1117, Hungary.

ORCID-Profile: Sabine Zitzmann-Kolbe, Ingrid Moen, Balázs Madas, Steffen Happel, Christoph Schatz, Harun Taş, Urs B Hagemann, Martina Benešová-Schäfer

Förderung

  • Deutsches Krebsforschungszentrum (DKFZ)

Zitieren

APA

Zitzmann-Kolbe, S., Remde, Y., Moen, I., Madas, B., Mázik, L., Suurs, F., Happel, S., Schäfer, M., Schatz, C., Taş, H., Hagemann, U. B., & Benešová-Schäfer, M. (2025). Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up. European Journal of Nuclear Medicine and Molecular Imaging, 53(1), 633-646. https://doi.org/10.1007/s00259-025-07427-4

Vancouver

Zitzmann-Kolbe S, Remde Y, Moen I, Madas B, Mázik L, Suurs F, et al. Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up. European Journal of Nuclear Medicine and Molecular Imaging. 2025;53(1):633-646. doi:10.1007/s00259-025-07427-4

BibTeX
@article{ZitzmannKolbe2025,
  author = {Zitzmann-Kolbe, Sabine and Remde, Yvonne and Moen, Ingrid and Madas, Balázs and Mázik, László and Suurs, Frans and Happel, Steffen and Schäfer, Martin and Schatz, Christoph and Taş, Harun and Hagemann, Urs B and Benešová-Schäfer, Martina},
  title = {Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {53},
  number = {1},
  pages = {633--646},
  doi = {10.1007/s00259-025-07427-4}
}
Kostenlos starten →